Form 4: Lemaitre Vascular Director Ross Bridget A. Exercises Options and Sells Shares
SEC Form 4 Filing
Director Ross Bridget A. of Lemaitre Vascular exercised stock options and sold shares on May 12, 2025.
Summary
- On May 12, 2025, Ross Bridget A., a director of Lemaitre Vascular, exercised stock options to acquire 3,750 shares of common stock at a price of $30 per share.
- Simultaneously, Ross Bridget A. sold 3,750 shares of common stock at a weighted average price of $83.20, with individual trades ranging from $83.20 to $83.21.
- Following these transactions, Ross Bridget A. directly owns 2,916 shares of Lemaitre Vascular common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 04/28/2020 | Date stock options became exercisable |
| 05/12/2025 | Date of stock option exercise and share sale |
| 04/28/2025 | Expiration date of stock options |
| 05/14/2025 | Date of signature on the Form 4 filing |
Keywords
Lemaitre Vascular, Director, Stock Options, Share Sale, Form 4, LMAT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.